1.07Medioshttps://7medios.comadminhttps://7medios.com/author/admin/Chimeric Antibody Against HER2: An Overview - 7Mediosrich600338<blockquote class="wp-embedded-content" data-secret="bGRB7nB7tI"><a href="https://7medios.com/chimeric-antibody-against-her2-an-overview/">Chimeric Antibody Against HER2: An Overview</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://7medios.com/chimeric-antibody-against-her2-an-overview/embed/#?secret=bGRB7nB7tI" width="600" height="338" title="“Chimeric Antibody Against HER2: An Overview” — 7Medios" data-secret="bGRB7nB7tI" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://7medios.com/wp-content/uploads/2022/11/image1.jpg1600915Immunotherapy with anti-HER2 antibodies has been emerging to be promising for patients with HER2-positive breast cancer. With the recent reports of characterization with mouse monoclonal antibody that has been against HER2, they bind to the epitope different from the trastuzumab recognition and specifically plays a role in inhibiting the proliferation of tumor cells overexpressing HER2.